A retrospective study found that women who took a GLP-1 drug for obesity were more likely to be diagnosed with acne vulgaris ...

Bagsværd, Denmark-based Novo Nordisk is a global healthcare company and a prominent player in the diabetes market with a full portfolio of glucagon ... care, growth hormone therapy, hormone ...

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

India’s weight loss category is undergoing a dynamic transformation triggered by scientific improvements, pharma innovation, and growing consumer demand ...

Research reveals GLP-1 receptor agonists influence gut microbiome, enhancing metabolic health and offering anti-inflammatory ...

Eating protein in the morning helps control cravings, supports metabolism, and makes weight loss more sustainable.

I’m Kelly Grant, a health reporter with The Globe and Mail. Yesterday, the Canadian Medical Association Journal published the first new guideline on the treatment of childhood obesity in nearly 20 ...

GLP-1's are a category of prescription medications labeled as glucagon-like peptide-1's ... But they do basically the same thing. They mimic a hormone that the body is supposed to produce ...

Denmark’s economy was reshaped by Novo Nordisk and obesity drugs. That identity now is under attack on multiple fronts, from ...

Antibiotic Exposure in Infancy May Boost Type 1 Diabetes Risk Mar. 25, 2025 — Exposure to antibiotics during a key developmental window in infancy can stunt growth of insulin-producing cells in ...